S&P 500   3,096.63 (+0.08%)
DOW   27,781.96 (-0.01%)
QQQ   201.43 (-0.08%)
AAPL   262.64 (-0.69%)
FB   193.15 (-0.02%)
MSFT   148.06 (+0.51%)
GOOGL   1,309.15 (+1.00%)
AMZN   1,754.60 (+0.08%)
CGC   15.84 (-14.38%)
NVDA   209.79 (+0.58%)
MU   46.80 (+1.08%)
BABA   182.80 (+0.18%)
GE   11.29 (+0.00%)
TSLA   349.35 (+0.94%)
T   38.95 (-0.54%)
AMD   38.35 (+2.21%)
F   8.79 (-0.23%)
ACB   3.29 (-7.32%)
PRI   130.20 (+1.24%)
NFLX   289.62 (+2.30%)
BAC   32.70 (-0.27%)
GILD   63.81 (+0.76%)
DIS   147.15 (-1.06%)
S&P 500   3,096.63 (+0.08%)
DOW   27,781.96 (-0.01%)
QQQ   201.43 (-0.08%)
AAPL   262.64 (-0.69%)
FB   193.15 (-0.02%)
MSFT   148.06 (+0.51%)
GOOGL   1,309.15 (+1.00%)
AMZN   1,754.60 (+0.08%)
CGC   15.84 (-14.38%)
NVDA   209.79 (+0.58%)
MU   46.80 (+1.08%)
BABA   182.80 (+0.18%)
GE   11.29 (+0.00%)
TSLA   349.35 (+0.94%)
T   38.95 (-0.54%)
AMD   38.35 (+2.21%)
F   8.79 (-0.23%)
ACB   3.29 (-7.32%)
PRI   130.20 (+1.24%)
NFLX   289.62 (+2.30%)
BAC   32.70 (-0.27%)
GILD   63.81 (+0.76%)
DIS   147.15 (-1.06%)
S&P 500   3,096.63 (+0.08%)
DOW   27,781.96 (-0.01%)
QQQ   201.43 (-0.08%)
AAPL   262.64 (-0.69%)
FB   193.15 (-0.02%)
MSFT   148.06 (+0.51%)
GOOGL   1,309.15 (+1.00%)
AMZN   1,754.60 (+0.08%)
CGC   15.84 (-14.38%)
NVDA   209.79 (+0.58%)
MU   46.80 (+1.08%)
BABA   182.80 (+0.18%)
GE   11.29 (+0.00%)
TSLA   349.35 (+0.94%)
T   38.95 (-0.54%)
AMD   38.35 (+2.21%)
F   8.79 (-0.23%)
ACB   3.29 (-7.32%)
PRI   130.20 (+1.24%)
NFLX   289.62 (+2.30%)
BAC   32.70 (-0.27%)
GILD   63.81 (+0.76%)
DIS   147.15 (-1.06%)
S&P 500   3,096.63 (+0.08%)
DOW   27,781.96 (-0.01%)
QQQ   201.43 (-0.08%)
AAPL   262.64 (-0.69%)
FB   193.15 (-0.02%)
MSFT   148.06 (+0.51%)
GOOGL   1,309.15 (+1.00%)
AMZN   1,754.60 (+0.08%)
CGC   15.84 (-14.38%)
NVDA   209.79 (+0.58%)
MU   46.80 (+1.08%)
BABA   182.80 (+0.18%)
GE   11.29 (+0.00%)
TSLA   349.35 (+0.94%)
T   38.95 (-0.54%)
AMD   38.35 (+2.21%)
F   8.79 (-0.23%)
ACB   3.29 (-7.32%)
PRI   130.20 (+1.24%)
NFLX   289.62 (+2.30%)
BAC   32.70 (-0.27%)
GILD   63.81 (+0.76%)
DIS   147.15 (-1.06%)
Log in

Surgery Partners Stock Price, Forecast & Analysis (NASDAQ:SGRY)

$11.50
-0.06 (-0.52 %)
(As of 11/14/2019 04:00 PM ET)
Today's Range
$11.30
Now: $11.50
$11.79
50-Day Range
$7.05
MA: $8.28
$11.76
52-Week Range
$5.38
Now: $11.50
$14.69
Volume327,100 shs
Average Volume317,415 shs
Market Capitalization$569.32 million
P/E RatioN/A
Dividend YieldN/A
Beta2.35
Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and related services in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. Read More…

Industry, Sector and Symbol

Industry General medical & surgical hospitals
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SGRY
CUSIPN/A
Phone615-234-5900

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.77 billion
Book Value$20.33 per share

Profitability

Net Income$-205,710,000.00

Miscellaneous

Employees11,000
Market Cap$569.32 million
Next Earnings Date3/11/2020 (Estimated)
OptionableOptionable

Receive SGRY News and Ratings via Email

Sign-up to receive the latest news and ratings for SGRY and its competitors with MarketBeat's FREE daily newsletter.


Surgery Partners (NASDAQ:SGRY) Frequently Asked Questions

What is Surgery Partners' stock symbol?

Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY."

How will Surgery Partners' stock buyback program work?

Surgery Partners announced that its Board of Directors has initiated a share repurchase program on Saturday, December 16th 2017, which authorizes the company to repurchase $50,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to buy shares of its stock through open market purchases. Stock repurchase programs are typically an indication that the company's management believes its shares are undervalued.

How were Surgery Partners' earnings last quarter?

Surgery Partners Inc (NASDAQ:SGRY) issued its earnings results on Tuesday, November, 5th. The company reported ($0.28) EPS for the quarter, topping analysts' consensus estimates of ($0.34) by $0.06. The firm had revenue of $452 million for the quarter, compared to analyst estimates of $452.30 million. Surgery Partners had a negative return on equity of 5.32% and a negative net margin of 11.26%. Surgery Partners's quarterly revenue was up 1.8% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.19) earnings per share. View Surgery Partners' Earnings History.

When is Surgery Partners' next earnings date?

Surgery Partners is scheduled to release their next quarterly earnings announcement on Wednesday, March 11th 2020. View Earnings Estimates for Surgery Partners.

What price target have analysts set for SGRY?

2 brokerages have issued 12-month target prices for Surgery Partners' shares. Their forecasts range from $12.00 to $12.00. On average, they expect Surgery Partners' share price to reach $12.00 in the next year. This suggests a possible upside of 4.3% from the stock's current price. View Analyst Price Targets for Surgery Partners.

What is the consensus analysts' recommendation for Surgery Partners?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Surgery Partners.

Has Surgery Partners been receiving favorable news coverage?

Headlines about SGRY stock have been trending somewhat negative this week, according to InfoTrie Sentiment. The research group scores the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Surgery Partners earned a media sentiment score of -1.4 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Surgery Partners.

Are investors shorting Surgery Partners?

Surgery Partners saw a increase in short interest in October. As of October 31st, there was short interest totalling 7,100,000 shares, an increase of 6.9% from the September 30th total of 6,640,000 shares. Based on an average daily volume of 335,200 shares, the short-interest ratio is presently 21.2 days. Currently, 34.6% of the company's shares are sold short. View Surgery Partners' Current Options Chain.

Who are some of Surgery Partners' key competitors?

What other stocks do shareholders of Surgery Partners own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Surgery Partners investors own include Mazor Robotics (MZOR), Allena Pharmaceuticals (ALNA), Rigel Pharmaceuticals (RIGL), Visa (V), Athersys (ATHX), Xilinx (XLNX), Liberty Oilfield Services (LBRT), SM Energy (SM), American Airlines Group (AAL) and Ardelyx (ARDX).

Who are Surgery Partners' key executives?

Surgery Partners' management team includes the folowing people:
  • Mr. Wayne Scott DeVeydt, CEO & Director (Age 49)
  • Mr. Thomas Francis Cowhey, Exec. VP, CFO & Principal Accounting Officer (Age 47)
  • Ms. Jennifer B. Baldock, Exec. VP & Chief Legal Officer (Age 48)
  • Dr. Angela Justice Ph.D., Exec. VP & Chief HR Officer (Age 46)
  • Mr. George M. Goodwin, Pres of American Group (Age 58)

Who are Surgery Partners' major shareholders?

Surgery Partners' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Alberta Investment Management Corp (0.09%) and Rhumbline Advisers (0.07%). Company insiders that own Surgery Partners stock include Adam T Feinstein, Brandan Lingle, Jason Eric Evans and Teresa Deluca. View Institutional Ownership Trends for Surgery Partners.

Which institutional investors are buying Surgery Partners stock?

SGRY stock was bought by a variety of institutional investors in the last quarter, including Alberta Investment Management Corp and Rhumbline Advisers. Company insiders that have bought Surgery Partners stock in the last two years include Jason Eric Evans and Teresa Deluca. View Insider Buying and Selling for Surgery Partners.

How do I buy shares of Surgery Partners?

Shares of SGRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Surgery Partners' stock price today?

One share of SGRY stock can currently be purchased for approximately $11.50.

How big of a company is Surgery Partners?

Surgery Partners has a market capitalization of $569.32 million and generates $1.77 billion in revenue each year. The company earns $-205,710,000.00 in net income (profit) each year or ($2.45) on an earnings per share basis. Surgery Partners employs 11,000 workers across the globe.View Additional Information About Surgery Partners.

What is Surgery Partners' official website?

The official website for Surgery Partners is http://www.surgerypartners.com/.

How can I contact Surgery Partners?

Surgery Partners' mailing address is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. The company can be reached via phone at 615-234-5900 or via email at [email protected]


MarketBeat Community Rating for Surgery Partners (NASDAQ SGRY)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  215 (Vote Outperform)
Underperform Votes:  288 (Vote Underperform)
Total Votes:  503
MarketBeat's community ratings are surveys of what our community members think about Surgery Partners and other stocks. Vote "Outperform" if you believe SGRY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SGRY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/14/2019 by MarketBeat.com Staff

Featured Article: Market Timing

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel